ORM 11372
Alternative Names: ORM-11372Latest Information Update: 28 Nov 2024
Price :
$50 *
At a glance
- Originator Orion
- Class Anti-ischaemics; Antiarrhythmics; Heart failure therapies
- Mechanism of Action Sodium-calcium exchanger inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Arrhythmias; Heart failure; Ischaemia
Most Recent Events
- 28 Nov 2024 No recent reports of development identified for preclinical development in Arrhythmias in Finland
- 28 Nov 2024 No recent reports of development identified for preclinical development in Heart-failure in Finland
- 28 Nov 2024 No recent reports of development identified for preclinical development in Ischaemia in Finland